Inhibition of dynamin and disruption of lipid rafts blocked entry and infection of nonpolarized HeLa cells by both DAF-binding and non-DAF-binding coxsackievirus B3 isolates.
CVB3 entry into nonpolarized HeLa cells requires dynamin and lipid rafts and is independent of DAF binding, demonstrating that viral entry mechanisms differ significantly depending on cell polarization.
Group B coxsackieviruses (CVB) use the CVB and adenovirus receptor (CAR) to enter and infect cells. Some CVB also bind to decay-accelerating factor (DAF), but that interaction alone is insufficient for infection. We previously found that CVB3 entry into polarized human intestinal cells (Caco-2) occurs by a caveolin-dependent but dynamin-independent mechanism that requires DAF-mediated tyrosine kinase signals. In this study, we examined how CVB enter and infect nonpolarized HeLa cells and how DAF binding affects these processes. Using immunofluorescence microscopy and a combination of dominant-negative proteins, small interfering RNAs, and drugs targeting specific endocytic pathways, we found that both DAF-binding and non-DAF-binding virus isolates require dynamin and lipid rafts to enter and infect cells. Unlike what we observed in Caco-2 cells, CVB3 entered HeLa cells with CAR. We found no role for clathrin, endosomal acidification, or caveolin. Inhibition of tyrosine kinases blocked an early event in infection but did not prevent entry of virus into the cell. These results indicate that CVB3 entry into nonpolarized HeLa cells differs significantly from entry into polarized Caco-2 cells and is not influenced by virus binding to DAF.
Patel et al. (Thu,) conducted a other in Coxsackievirus B infection. Dynamin inhibitors (dynasore, siRNA) and lipid raft disruptors (filipin, MβCD) vs. Control cells (DMSO, negative control siRNA) was evaluated on Viral entry and infection (percentage of cells expressing newly synthesized viral antigen). Inhibition of dynamin and disruption of lipid rafts blocked entry and infection of nonpolarized HeLa cells by both DAF-binding and non-DAF-binding coxsackievirus B3 isolates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: